Baxter International Inc (NYSE:BAX)
$ 33.9 -0.1 (-0.29%) Market Cap: 17.27 Bil Enterprise Value: 28.42 Bil PE Ratio: 6.52 PB Ratio: 2.11 GF Score: 75/100

Baxter International Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 14, 2022 / 02:35PM GMT
Release Date Price: $59.11 (+1.69%)
Andrew Christopher Ranieri
Morgan Stanley, Research Division - Equity Analyst

Great. Thanks, everyone, for joining another session at the conference. I'm Drew Ranieri, one of the medical device analysts here. And it's my absolute pleasure to have Baxter International with us today, CFO, Jay Saccaro; and VP of Investor Relations, Clare Trachtman.

Before we go into Q&A, just to highlight the disclosure, but for important disclosures, please see the Morgan Stanley research disclosure website. And if you have any questions, reach out to your Morgan Stanley sales rep.

Questions & Answers

Andrew Christopher Ranieri
Morgan Stanley, Research Division - Equity Analyst

So Jay, on to Q&A, and thank you again for being here. And kind of with the rumor that came out last night about potential asset sales, I know you won't necessarily comment on it specifically, but I mean, there has been a lot happening in the renal space from the corporate action side in 2022 on top of some government regulatory positive changes in targeting, moving care into

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot